StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) income statement

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$40.40+0.75 (+1.89%)

Close on Oct 19, 2026Market cap $98.22MP/E –Yield –

See a number that looks wrong?